
Neuroweek 2022 – Factor XI inhibition for stroke secondary prevention «somewhat disappointing»
Key messages Two new factor XI inhibitors (FXI) developed for the secondary prevention of stroke have «yielded somewhat disappointing results» in recent studies, according to Prof. Matthias Endres from the Department of Neurology at the Charité Hospital in Berlin at Neurowoche 2022. Background Inhibition of blood clotting with FXI as a promising target for secondary […]